Hello friends! Wow there are some exciting medications in the works. Let's talk about something currently being studied, a medication that targets 3 different receptor pathways in the GI tract. It's one to watch!

References:
AM Jastreboff et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity--A Phase 2 Trial. N Engl J Med. 2023 Aug 10;389(6):514-526.
PMID: 37366315

свернуть